BIG
TNGX icon

Brooklyn Investment Group’s Tango Therapeutics TNGX Stock Holding History

Brooklyn Investment Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,566
Closed -$9K – 3409
2025
Q1 		$9K Buy
6,566
+5,879
+856% +$14.4K ﹤0.01% 1560
2024
Q4 		$2.12K Buy
+687
New +$3.19K ﹤0.01% 1442

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

Brooklyn Investment Group's TNGX Position: Q2 2025 in Review

Brooklyn Investment Group sold out of Tango Therapeutics (TNGX) in Q2 2025, closing a stake of 6,566 shares — an estimated $9K sold.

Brooklyn Investment Group first reported a position in TNGX in Q4 2024 and held it in 2 quarters. The position peaked at $9K in Q1 2025. 115 funds tracked by Wall St. Rank hold TNGX as of Q2 2025.

  • Brooklyn Investment Group reported no remaining Tango Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 6,566 Tango Therapeutics shares in Q2 2025, an estimated $9K.
  • Brooklyn Investment Group first reported a position in Tango Therapeutics in Q4 2024 and held it in 2 quarters.
  • Brooklyn Investment Group's Tango Therapeutics position peaked at $9K in Q1 2025.
  • 115 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2025.

Based on Brooklyn Investment Group's 13F filing for Q2 2025, filed 12 Aug 2025.